AWM Investment Company, Inc. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 137 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
AWM Investment Company, Inc. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$534,000
-4.3%
92,2000.0%0.11%
-2.6%
Q1 2016$558,000
-33.7%
92,2000.0%0.12%
-29.5%
Q4 2015$842,000
+61.9%
92,2000.0%0.17%
+64.4%
Q3 2015$520,000
-71.1%
92,200
-43.2%
0.10%
-60.4%
Q2 2015$1,799,000
-33.4%
162,200
-5.8%
0.26%
-31.6%
Q1 2015$2,700,000
-61.4%
172,200
-62.6%
0.37%
-60.9%
Q4 2014$6,997,000460,0000.95%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Rokos Capital Management LLP 6,474,348$11,394,8520.84%
WASATCH ADVISORS LP 13,642,417$24,010,6540.15%
Avidity Partners Management LP 2,470,000$4,347,2000.14%
Acrisure Capital Management, LLC 75,832$133,4640.14%
Golden State Equity Partners 135,765$238,9460.13%
Long Focus Capital Management, LLC 1,072,000$1,886,7200.11%
KLK CAPITAL MANAGEMENT LLC 44,323$78,0080.10%
CAXTON ASSOCIATES LP 288,218$507,2640.08%
XTX Topco Ltd 206,334$363,1480.08%
Rhenman & Partners Asset Management AB 314,157$534,0670.06%
View complete list of SANGAMO THERAPEUTICS INC shareholders